menu search

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-...

November 3, 2023, 7:41 pm

Pdd holdings inc. (pdd) exceeds market returns: some facts to consider

PDD Holdings Inc. (PDD) concluded the recent trading session at $102.93, signifying a +1.49% move from ...

November 1, 2023, 6:47 pm

Nike (nke) outperforms broader market: what you need to know

Nike (NKE) reachead $102.77 at the closing of the latest trading day, reflecting a +0.95% change compar...

October 31, 2023, 6:47 pm

Us consumer confidence fell to 102.6, third month of decline

Conference Board’s Consumer Confidence Index in the US recorded a dip in October 2023, falling from 104.3 to ...

October 31, 2023, 2:12 pm

Us october consumer confidence 102.6 vs 100.0 expected

Prior was 103.0 (revised to 104.3)Details:Present situation index 143.1 vs 147.1 prior Expectations index 75.6 vs 73.7 prior 1 year Inflation 5.9% vs ...

October 31, 2023, 2:00 pm

Gold prices hold above $2,000 an ounce as u.s. consumer confidence falls less than expected to 102.6

(Kitco News) -The gold market continues to trade near session highs above $2,000 an ounce even as U.S. consumers remains slightly more optimistic abou...

October 31, 2023, 10:08 am

Akamai technologies (akam) rises but trails market: what investors should know

In the most recent trading session, Akamai Technologies (AKAM) closed at $102.57, indicating a +0.55% s...

October 30, 2023, 7:33 pm

: stock of hoka sneaker maker deckers soars 10% on earnings beat

Deckers Outdoor Corp. DECK shares rallied 10% in the aftermarket Thursday after the maker of Ugg boots and Hoka sneakers reported fiscal second-quarte...

October 26, 2023, 9:20 pm

Stock of hoka sneaker maker deckers soars 10% on earnings beat

Deckers Outdoor Corp. DECK, -1.59% shares rallied 10% in the aftermarket Thursday after the maker of Ugg boots and Hoka sneakers reported fiscal secon...

October 26, 2023, 5:20 pm

United states gdp constant prices

GDP Constant Prices in the United States increased to 22491.60 USD Billion in the third quarter of 2023 from 22225.40 USD Billion in the second quarte...

October 26, 2023, 12:57 pm

Imax's oppenheimer boost delivers “spectacular” quarter

IMAX Corp (NYSE:IMAX) stock was boosted Wednesday as Christopher Nolan's Oppenheimer helped drive the immersive big screen cinema brand to better-than...

October 25, 2023, 9:06 am

Japan leading economic index

Leading Economic Index Japan increased to 109.20 in August of 2023 over the same month in the previous year. Leading Economic Index in Japan averaged ...

October 25, 2023, 5:10 am

Pboc sets usd/ cny reference rate for today at 7.1785 (vs. estimate at 7.3213)

The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. Its permitted to trade...

October 25, 2023, 1:18 am

Kuaishou technology to report 2023 third quarter financial results on november 21, 2023

HONG KONG , Oct. 24, 2023 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HK Counter: 0102...

October 24, 2023, 4:41 am

Canada new motor vehicle sales

Car Registrations in Canada decreased to 147401 Units in July from 168591 Units in June of 2023. Car Registrations in Canada averaged ...

October 23, 2023, 3:44 pm

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am


Search within

Pages Search Results: